BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 15905550)

  • 21. The p41 isoform of invariant chain is a chaperone for cathepsin L.
    Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
    EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
    Mihelic M; Dobersek A; Guncar G; Turk D
    J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
    El-Sukkari D; Wilson NS; Hakansson K; Steptoe RJ; Grubb A; Shortman K; Villadangos JA
    J Immunol; 2003 Nov; 171(10):5003-11. PubMed ID: 14607896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct protease requirements for antigen presentation in vitro and in vivo.
    Matthews SP; Werber I; Deussing J; Peters C; Reinheckel T; Watts C
    J Immunol; 2010 Mar; 184(5):2423-31. PubMed ID: 20164435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteases involved in MHC class II antigen presentation.
    Villadangos JA; Bryant RA; Deussing J; Driessen C; Lennon-Duménil AM; Riese RJ; Roth W; Saftig P; Shi GP; Chapman HA; Peters C; Ploegh HL
    Immunol Rev; 1999 Dec; 172():109-20. PubMed ID: 10631941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
    Manoury B; Gregory WF; Maizels RM; Watts C
    Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis.
    Nepal RM; Vesosky B; Turner J; Bryant P
    J Leukoc Biol; 2008 Oct; 84(4):1011-8. PubMed ID: 18591414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.
    Burster T; Beck A; Tolosa E; Marin-Esteban V; Rötzschke O; Falk K; Lautwein A; Reich M; Brandenburg J; Schwarz G; Wiendl H; Melms A; Lehmann R; Stevanovic S; Kalbacher H; Driessen C
    J Immunol; 2004 May; 172(9):5495-503. PubMed ID: 15100291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
    Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
    J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
    Rajagopalan G; Smart MK; Krco CJ; David CS
    J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
    Rodriguez GM; Diment S
    Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Hsing LC; Rudensky AY
    Immunol Rev; 2005 Oct; 207():229-41. PubMed ID: 16181340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway.
    Zwickey HL; Potter TA
    J Immunol; 1999 Jun; 162(11):6341-50. PubMed ID: 10352246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.
    Slavin AJ; Soos JM; Stuve O; Patarroyo JC; Weiner HL; Fontana A; Bikoff EK; Zamvil SS
    J Clin Invest; 2001 Oct; 108(8):1133-9. PubMed ID: 11602620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathepsin S activity regulates antigen presentation and immunity.
    Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
    J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.
    Mallet-Designe VI; Stratmann T; Homann D; Carbone F; Oldstone MB; Teyton L
    J Immunol; 2003 Jan; 170(1):123-31. PubMed ID: 12496391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.